Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
Rattachement africain : be. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
In the last two decades, robotic-assisted thoracoscopic surgery (RATS) has gained popularity as a minimally invasive surgical (MIS) alternative to multi- and uniportal video-assisted thoracoscopic surgery (VATS). With this approach, the surgeon obviates the known drawbacks of conventional MIS, such as the reduced in-depth perception, hand-eye coordination, and freedom of motion of the instruments. Previous studies have shown that a robotic approach for operable lung cancer has treatment outcomes comparable to other MIS techniques such as multi-and uniportal VATS, but with less blood loss, a lower conversion rate to open surgery, better lymph node dissection rates, and improved ergonomics for the surgeon. The thoracic surgeon of the future is expected to perform more complex procedures. More patients will enter a multimodal treatment scheme making surgery more difficult due to severe inflammation. Furthermore, due to lung cancer screening programs, the number of patients presenting with operable smaller lung nodules in the periphery of the lung will increase. This, combined with the fact that segmentectomy is becoming an increasingly popular treatment for small peripheral lung lesions, indicates that the future thoracic surgeons need to have profound knowledge of segmental resections. New imaging techniques will help them to locate these lesions and to achieve a complete oncologic resection. Current robotic techniques exist to help the thoracic surgeon overcome these challenges. In this review, an update of the latest MIS approaches and nodule detection techniques will be given.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
- Date Crossref
- 26/08/2023
- Éditeur
- MDPI AG
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Antwerp Department of Thoracic and Vascular Surgery pays non établi dans la noticeUniversité ou école supérieure
-
Antwerp University Hospital Department of Thoracic and Vascular Surgery pays non établi dans la noticeOrganisme public
-
Anatomy and Research Centre (ASTARC) Antwerp Surgical Training pays non établi dans la noticeStructure de recherche
Department of Thoracic and Vascular Surgery — University of Antwerp, Department of Thoracic and Vascular Surgery — Antwerp University Hospital et Antwerp Surgical Training — Anatomy and Research Centre (ASTARC).
Une affiliation ne permet pas de déduire la nationalité d’un auteur.